MicroRNAs As Novel Antiarrhythmic Targets for Atrial Fibrillation.

Zhiqiang Zhao,Tong Liu,Xinghua Wang,Guangping Li
DOI: https://doi.org/10.1016/j.ijcard.2013.08.014
IF: 4.039
2013-01-01
International Journal of Cardiology
Abstract:Atrial fibrillation (AF) is a ubiquitous yet diverse cardiac arrhythmia with an overall prevalence of 1% in the general population and up to 8% in patients who are >80 years of age [ [1] Xiao J. Liang D. Zhao H. et al. 2-Aminoethoxydiphenyl borate, a inositol 1,4,5-triphosphate receptor inhibitor, prevents atrial fibrillation. Exp Biol Med (Maywood). 2010; 235: 862-868 Crossref PubMed Scopus (24) Google Scholar ]. It has been recognized as an important risk factor for short-term morbidity and decreased long-term survival [ [2] Saxena A. Dinh D.T. Smith J.A. et al. Usefulness of postoperative atrial fibrillation as an independent predictor for worse early and late outcomes after isolated coronary artery bypass grafting (multicenter Australian study of 19,497 patients). Am J Cardiol. 2012; 109: 219-225 Abstract Full Text Full Text PDF PubMed Scopus (121) Google Scholar ]. Moreover, it was reported that hospital stay is longer, and in-hospital mortality is significantly higher among the patients with AF compared with the sinus rhythm group [ [3] Attaran S. Shaw M. Bond L. Pullan M.D. Fabri B.M. A comparison of outcome in patients with preoperative atrial fibrillation and patients in sinus rhythm. Ann Thorac Surg. 2011; 92: 1391-1395 Abstract Full Text Full Text PDF PubMed Scopus (25) Google Scholar ]. Despite the fact that the pathophysiology of AF has been investigated extensively for almost a century, the precise mechanism of AF is still unknown and most of the evidence suggests it is multi-factorial [ [4] Alqahtani A.A. Atrial fibrillation post cardiac surgery trends toward management. Heart Views. 2010; 11: 57-63 Crossref PubMed Google Scholar ]. Currently available therapeutic approaches have major limitations. Thus, an improved understanding of the mechanisms underlying AF is essential for the development of novel therapeutic approaches [ [5] Nattel S. From guidelines to bench: implications of unresolved clinical issues for basic investigations of atrial fibrillation mechanisms. Can J Cardiol. 2011; 27: 19-26 Abstract Full Text Full Text PDF PubMed Scopus (48) Google Scholar ].
What problem does this paper attempt to address?